tweenvest

Eocene Ltd. (NasdaqCM: EOCN)

Health Care · Biotechnology · IL

$2.48

+3.77% today · -70.5% 1Y

Public summary
A free snapshot of Eocene Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Eocene Ltd. (NasdaqCM: EOCN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.58M and employs 6 people.

Over the last twelve months the share price has lost 70.5%, trading between 2.33 and 12.32.

Tweenvest scores Eocene Ltd. across four factors: quality 37/100, value 56/100. Its strongest factor is value.

EOCN price history

Nov 21, 2025 · 6.70Weekly closes 2.48 – 8.96Nov 13, 2026 · 2.48

Key figures

Market cap
$2.58M
Revenue (TTM)
—
P/E
-0.23
EPS
-14.54
Dividend yield
—
Beta (5Y)
0.72
52-week high
$12.32
52-week low
$2.33
Avg volume (3M)
—
Shares outstanding
1.04M
Employees
6
Next earnings
—

About Eocene Ltd.

Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.

ISIN
IL0011313900
Founded
2000
Listed since
Mar 12, 2014
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Ernexa Therapeutics Inc.NasdaqCM: ERNA$2.86M$1.69+0.60%
Restart Life Sciences Corp.CNSX: HEAL$2.85MCA$0.07-18.75%
Vaccinex, Inc.OTCPK: VCNX$2.68M$1.000.00%
Spermosens AB (publ)NGM: SPERM$2.67MSkr0.01+2.44%
Modus Therapeutics Holding AB (publ)OM: MODTX$2.55MSkr0.17+2.99%
Curis, Inc.NasdaqCM: CRIS$2.52M$0.61+13.38%
Dermata Therapeutics, Inc.NasdaqCM: DRMA$2.50M$0.62-6.01%
Quantum Genesis AI Corp.OTCPK: QGAI$2.46M$0.06+114.29%

Browse every Biotechnology company →